Emergent BioSolutions Inc.
Emergent BioSolutions Inc. (EBS) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 1022 transactions totaling $178.3M, demonstrating a bearish sentiment with -$178.1M in net insider flow. The most recent transaction on Feb 9, 2026 involved a transaction of 918 shares valued at $10.1K.
EBS Insider Activity Summary
Who Is Buying EBS Stock?
No significant insider buying has been recorded for EBS in the recent period.
Who Is Selling EBS Stock?
No significant insider selling has been recorded for EBS in the recent period.
Is Emergent BioSolutions Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for EBS is bearish with an Insider Alignment Score of 0/100 and a net flow of -$178.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
EBS Frequently Asked Questions
Understanding EBS Insider Activity
Insider trading at Emergent BioSolutions Inc. (EBS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading EBS stock, having executed 1022 transactions in the past 90 days. The most active insider is Fuad El-hibri (Executive), who has made 187 transactions totaling $108.8M.
Related Tools
Track Emergent BioSolutions Inc. Insider Activity
Get notified when executives and directors at EBS file new Form 4 transactions